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better in the breast-fed arm, significantly so in the first 6
months. The cardinal point to remember is that these
similarities in outcome, and the nutritional benefit of breast-
feeding, occurred after 24 months (median duration of breast-
feeding 17 months), when the HIV infection rate in the breast-
feeding arm was a whopping 37% compared with 21% in the
formula arm. Accordingly breast-feeding over this prolonged
period remained effective for these outcomes despite the very
high HIV infection rate; the obvious answer is to reduce HIV
transmission through breast-feeding while retaining its
advantages! Six months provides adequate benefits of breast-
feeding, and the transmission risk of HIV is at worst about 5%
(the latter is from a meta-analysis of nine African trials
involving 4 085 children).4 If our group’s hypothesis is correct
this figure may be even lower with exclusive breast-feeding.
What is critical to the thrust of this letter is that in the
Nairobi trial all women ‘had access to potable water, extensive
health education regarding safe preparation of formula, a
reliable supply of formula, and access to medical care for their
infants’. So breast-feeding stood up to comparison with
formula in a developing country setting, which is as good as it
can get for minimising the disadvantages of formula.
There are other examples of breast-feeding in urban
environments. In Durban and Harare (an extremely large trial)
studies are detecting substantial benefits in children of HIV-
infected mothers who breast-feed in preference to formula-
feeding.
We have to promote solutions that are not abstracted from
this continent’s priorities and that respect the durability and
strength of African traditions; breast-feeding is more than just
about infant feeding, it affirms a wider public good.
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Auto-antibody testing in
obstetric patients
To the Editor: We read with interest the article by Afman et al.1
on the relationship of auto-antibodies and obstetric outcome in
a tertiary high-risk obstetric unit. In our view the lack of an
association between antinuclear antibodies (ANAs) and
adverse pregnancy outcome may be due to a fundamental
error in interpretation of the ANA results. The authors have
grouped the 33 true ANA-positive patients with the 13 patients
who had only an anti-cytoplasmic pattern on indirect
immunofluorescence (IIF) testing. The latter staining pattern is
a ‘by-product’ of the IIF test using HEp-2 cells, and in this
study is likely to be due to anti-parietal and anti-smooth
muscle antibodies that were presumably confirmed on tissue
substrate (method not given in paper). By definition, antibodies
directed at cytoplasmic components cannot be considered to be
ANAs. Hence, the comparison should have been between the
33 true ANA- positive patients and relevant control patients. A
secondary issue is that negative IIF does not rule out the
presence of anti-Ro antibodies even when HEp-2 cells are used
as substrate. Anti-Ro antibodies are highly associated with the
rare event of neonatal lupus and need to be sought by other
methods if there is any suspicion of this condition.
Secondly, it would have been helpful to know the total
number of patients in the two groups who were HIV-positive,
and the frequencies of the respective auto-antibodies. We also
note the finding that anticardiolipin (ACL) antibodies were
more frequent in women with severe pre-eclampsia. In a
previous study based on our own experience in a routine
antenatal clinic, ACL antibodies were poorly predictive for pre-
eclampsia,2 so the test may be more useful where there is a
higher pretest risk of an associated event. Finally, we feel the
title of the paper is not an accurate reflection of the study. ACL
antibodies are not directed against nuclear antigens. ‘Auto-
antibody testing in obstetric patients’ might be a more accurate
title and a better reflection of the nature of the study.
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Pressure chamber explosion —
Southern African Underwater
and Hyperbaric Medical
Association statement
To the Editor: Members of the Southern African Underwater
and  Hyperbaric Medical Association (SAUHMA), a special
interest group of  the South African Medical Association, were
shocked to learn of the death of the Eloff brothers when a
chamber they apparently built and used  exploded, killing
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